Platelet Aggregation After Strict Metabolic Control Using the Artificial Pancreas
Dear Sir, There is an increasing body of evidence to suggest that patients with diabetes mellitus have accelerated atherosclerotic vascular disease which seems primarily dependent on endothelial injury [l] . An increased sensitivity to platelet aggregating agents has been demonstrated in the majority of diabetic patients with established large and small vessel disease [2] . The biochemical events associated with the increased platelet sensitivity could be explained by an accelerated release of arachidonic acid from platelet membranes [3] . However, there is at present no substantial evidence to determine whether platelet hyperactivity is a cause or consequence of the small vessel complications of diabetes; neither is it clear whether platelet hyperactivity is an early event in diabetes or is secondary to the metabolic derangements of the disease.
We have investigated the role of strict metabolic control achieved with the aid of the artificial pancreas (Biostator, Miles, Cavenago Brianza, Italy) on platelet function. Ten diabetic patients (six females and four males) participated in the study (group 1). They were all insulin-dependent, age 15-50 years (mean 37 years) with a duration of known disease from 1 to 15 years (mean 10 years). Platelet function was assessed by determining platelet aggregation response to ADP (end concentration 1.25 p~mol/1) according to Born [4] and circulating platelet aggregates according to Wu and Hoak [5] . The results for circulating platelet aggregates are expressed as a ratio (platelet count ratio): this ratio approaches 1 in the absence of significant amounts of aggregates and drops below 1 when aggregates are present. The mean coefficient of varation of platelet count ratio measurements within samples is +_ 8%. Results are expressed as mean + SEM Table 1 shows that 24 h of strict metabolic control caused a complete normalization of blood glucose, a significant reduction of the aggregation response to ADP (p < 0.0l) and the disappearance of circulating platelet aggregates which were present in the basal state. Our results confirm the presence in human diabetes of platelet hyperactivity and demonstrate that these abnormal responses are reversed by strict metabolic control. The significance of these findings is strengthened by the lack of significant variation of platelet aggregation and platelet aggregates in a matched-group of diabetic patients whose glycaemic profile was only monitored during the study period (group 2 - Table 1 ) and by the recent findings of Juhan et al. [6] who observed a significant reduction of platelet hyperactivity in insulin-dependent diabetic patients after a similar period of strict metabolic control. It therefore seems likely that platelet hyperactivity is a consequence of the metabolic derangements of diabetes mellitus.
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